CCR2 and malignant pleural mesothelioma: Likewise, co-expression of CCR2b was also associated with an increased migration (12.5-fold) of mesothelin (MSLN)-targeted CAR-T cells toward malignant pleural mesothelioma, in a study conducted by Moon et al. (34).